PROFILE |
 |
Drugs are in the family blood for Boehringer Ingelheim. The family-owned company makes prescription, over-the-counter (OTC), and veterinary drugs and chemicals. Its pharmaceuticals include treatments for respiratory ailments (its best-selling product is bronchitis drug Atrovent), cardiovascular disease, and HIV. Boehringer also offers cold, gastrointestinal, and pain remedies; vitamins; minerals; and other products. Its veterinary supplies include vaccines and antibiotics. Founded as a chemical maker in 1885, Boehringer still makes bulk pharmaceutical ingredients and other chemicals for the food and drug industries. The Boehringer family controls the company through its parent, C.H. Boehringer Sohn.
COMPETITION |
 |
Aventis (AVE)
Bayer AG (BAYZY)
Merck & Co., Inc. (MRK)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 5,826.60
1-Yr. Sales Growth: 7.4%
Employees: 27,325
Revenue per employee: $213,233.30
KEY PEOPLE |
 |
Rolf Krebs
CEO
Marbod Muff
CFO
CONTACT INFO |
 |
Binger Strasse 173
D-55216 Ingelheim , Germany
Phone: 49-6132-770
Fax: 49-6132-77-3000
Online: Web Site
|